The Mycobacterium tuberculosis protein tyrosine phosphatase MptpA features a pH dependent activity overlapping the

Michael Kovermann1, Alessandra Stefan2, Chiara Palazzetti3

  • 1Department of Chemistry, University of Konstanz, Universitätstraße 10, 78464, Konstanz, Germany.

Biochimie
|May 18, 2023
PubMed

Insights

Mycobacterium tuberculosis MptpA, essential for virulence, loses catalytic efficiency and undergoes conformational changes in acidic conditions. This suggests targeting MptpA with inhibitors effective at low pH for tuberculosis treatment.

Area of Science:

  • Biochemistry
  • Microbiology
  • Structural Biology

Background:

  • Mycobacterium tuberculosis protein tyrosine phosphatase A (MptpA) is crucial for pathogenicity by inhibiting phagosome-lysosome fusion.
  • MptpA's function is linked to maintaining a non-acidic environment for bacterial survival within host cells.
  • Previous studies focused on MptpA's properties at neutral to alkaline pH (pH 8.0).

Purpose of the Study:

  • To investigate the pH-dependence of MptpA's structural and catalytic properties.
  • To understand how acidic conditions affect MptpA's interaction with phosphotyrosine (pTyr).
  • To evaluate the efficacy of MptpA inhibitors at acidic pH.

Main Methods:

  • Analysis of MptpA's structural and catalytic properties across a pH gradient.
  • Determination of kinetic parameters, including K0.5 for pTyr.
  • Surface plasmon resonance (SPR) to assess MptpA-pTyr binding.
  • Evaluation of inhibitor L335-M34 effectiveness at varying pH.

Main Results:

  • MptpA exhibits significant conformational changes and reduced catalytic efficiency at acidic pH.
  • Enzymatic activity decreases notably as pH drops below 6.5, with a pKa2 of 5.7 for the phosphotyrosine substrate.
  • MptpA shows poor binding to pTyr at pH < 6.5, while inhibitor L335-M34 demonstrates enhanced efficacy at pH 6.

Conclusions:

  • MptpA's function is highly sensitive to acidic pH, impacting its virulence role.
  • The findings suggest a strategy for developing novel anti-tuberculosis drugs targeting MptpA.
  • Competitive inhibitors with negatively charged groups and lower pKa values than the substrate phosphate are promising therapeutic candidates.